This grant, offered by the Centers for Disease Control and Prevention (CDC) to Uzbekistan’s Research Institute for Epidemiology, Microbiology and Infectious Diseases (RIEMID) of the Ministry of Health, aims to bolster the nation’s capacity against infectious disease threats. The primary purpose is establishing a Center for Genome Sequencing of Emerging, Re-Emerging Infectious Diseases. This involves providing staff training, specialized equipment, methodology sharing, and data analysis, which will significantly enhance COVID-19 transmission detection and new SARS-CoV-2 strain recognition. Additionally, the grant supports extending nationwide antimicrobial resistance (AMR) surveillance, promoting rational antimicrobial use, introducing genetic surveillance, improving rapid bacterial identification, and consolidating AMR data quality.
Opportunity ID: 333462
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2169 |
| Funding Opportunity Title: | Strengthening detection, prevention and response to infectious disease threats in Uzbekistan |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 11, 2021 |
| Last Updated Date: | May 11, 2021 |
| Original Closing Date for Applications: | Jul 10, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Jul 10, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Aug 11, 2021 |
| Estimated Total Program Funding: | $207,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases (RSSPMCEMIPD) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | Currently the Research Institute for Epidemiology, Microbiology and Infectious Diseases of the Ministry of Health of the Republic of Uzbekistan (RIEMID) is concluding activities under CDC Co-Ag GH001653 focused on antimicrobial resistance. RIEMID is designated to be the Center of genetic technologies by the Presidential Decree PP-4790 dated July 27, 2020. In this regard, CDC would like to work with RIEMID on non-research activities, including establishing a Center for Genome Sequencing of Emerging, Re-Emerging Infectious Diseases by 1) providing training and mentorship to the staff at the Center, 2) purchasing specialized gene sequencing equipment, 3) sharing established methodologies for sequencing of pathogens, 4) analyzing sequencing data, and 5) showing the relevance of sharing data with the global community. This Center would increase the capacity of Uzbekistan to detect, investigate, and report COVID-19 transmission. Uzbekistan will have the ability to recognize new strains or mutations of strain of SARS-CoV-2. Sequencing data would give the country (and others if shared) a deeper understanding of pathogen phylogeny, which can assist in vaccine production. In addition, CDC would like RIEMID to continue working on AMR surveillance, particularly extend it to the whole country, conduct non-research activities on strengthening the rational use of antimicrobials in the country, introduce genetic surveillance and new systems of rapid identification of bacteria (MALDI-TOF), improve quality of AMR data by assisting implementation of QMS in the bacteriology laboratories and consolidating the AMR data in RIEMID AMR reference center. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shana Eatman
wrf3@cdc.gov Email:wrf3@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Estimated application due date 7/10/2021 | May 11, 2021 | |
| May 11, 2021 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2169 |
| Funding Opportunity Title: | Strengthening detection, prevention and response to infectious disease threats in Uzbekistan |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 11, 2021 |
| Last Updated Date: | May 11, 2021 |
| Original Closing Date for Applications: | Jul 10, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Jul 10, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Aug 11, 2021 |
| Estimated Total Program Funding: | $207,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases (RSSPMCEMIPD) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | Currently the Research Institute for Epidemiology, Microbiology and Infectious Diseases of the Ministry of Health of the Republic of Uzbekistan (RIEMID) is concluding activities under CDC Co-Ag GH001653 focused on antimicrobial resistance. RIEMID is designated to be the Center of genetic technologies by the Presidential Decree PP-4790 dated July 27, 2020. In this regard, CDC would like to work with RIEMID on non-research activities, including establishing a Center for Genome Sequencing of Emerging, Re-Emerging Infectious Diseases by 1) providing training and mentorship to the staff at the Center, 2) purchasing specialized gene sequencing equipment, 3) sharing established methodologies for sequencing of pathogens, 4) analyzing sequencing data, and 5) showing the relevance of sharing data with the global community. This Center would increase the capacity of Uzbekistan to detect, investigate, and report COVID-19 transmission. Uzbekistan will have the ability to recognize new strains or mutations of strain of SARS-CoV-2. Sequencing data would give the country (and others if shared) a deeper understanding of pathogen phylogeny, which can assist in vaccine production. In addition, CDC would like RIEMID to continue working on AMR surveillance, particularly extend it to the whole country, conduct non-research activities on strengthening the rational use of antimicrobials in the country, introduce genetic surveillance and new systems of rapid identification of bacteria (MALDI-TOF), improve quality of AMR data by assisting implementation of QMS in the bacteriology laboratories and consolidating the AMR data in RIEMID AMR reference center. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shana Eatman
wrf3@cdc.gov Email:wrf3@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2169 |
| Funding Opportunity Title: | Strengthening detection, prevention and response to infectious disease threats in Uzbekistan |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 11, 2021 |
| Last Updated Date: | May 11, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jul 10, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Aug 11, 2021 |
| Estimated Total Program Funding: | $207,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases (RSSPMCEMIPD) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | Currently the Research Institute for Epidemiology, Microbiology and Infectious Diseases of the Ministry of Health of the Republic of Uzbekistan (RIEMID) is concluding activities under CDC Co-Ag GH001653 focused on antimicrobial resistance. RIEMID is designated to be the Center of genetic technologies by the Presidential Decree PP-4790 dated July 27, 2020. In this regard, CDC would like to work with RIEMID on non-research activities, including establishing a Center for Genome Sequencing of Emerging, Re-Emerging Infectious Diseases by 1) providing training and mentorship to the staff at the Center, 2) purchasing specialized gene sequencing equipment, 3) sharing established methodologies for sequencing of pathogens, 4) analyzing sequencing data, and 5) showing the relevance of sharing data with the global community. This Center would increase the capacity of Uzbekistan to detect, investigate, and report COVID-19 transmission. Uzbekistan will have the ability to recognize new strains or mutations of strain of SARS-CoV-2. Sequencing data would give the country (and others if shared) a deeper understanding of pathogen phylogeny, which can assist in vaccine production. In addition, CDC would like RIEMID to continue working on AMR surveillance, particularly extend it to the whole country, conduct non-research activities on strengthening the rational use of antimicrobials in the country, introduce genetic surveillance and new systems of rapid identification of bacteria (MALDI-TOF), improve quality of AMR data by assisting implementation of QMS in the bacteriology laboratories and consolidating the AMR data in RIEMID AMR reference center. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shana Eatman
wrf3@cdc.gov Email:wrf3@cdc.gov |
Related Documents
Folder 333462 Full Announcement-Full Announcement -> Foa_Content_of_CDC-RFA-GH21-2169.pdf
Packages
| Agency Contact Information: | Shana Eatman wrf3@cdc.gov Email: wrf3@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.318 | CDC-RFA-GH21-2169 | Strengthening detection, prevention and response to infectious disease threats in Uzbekistan | PKG00267055 | May 11, 2021 | Jul 10, 2021 | View |
Package 1
Mandatory forms
333462 SF424_3_0-3.0.pdf
333462 Project_AbstractSummary_2_0-2.0.pdf
333462 SFLLL_2_0-2.0.pdf
333462 SF424A-1.0.pdf
333462 BudgetNarrativeAttachments_1_2-1.2.pdf
333462 ProjectNarrativeAttachments_1_2-1.2.pdf
Optional forms
333462 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
